NCT06743035View on ClinicalTrials.gov

Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 3, 2024

Primary Completion Date

July 31, 2029

Study Completion Date

July 31, 2029

Conditions
Polycythemia Vera
Trial Locations (1)

30161

RECRUITING

Onkologisches Studienzentrum Dr. med. Ingo Zander & Dr. med. Eyck von der Heyde, Hanover

Sponsors
All Listed Sponsors
collaborator

AOP Orphan Pharmaceuticals Germany GmbH

UNKNOWN

lead

iOMEDICO AG

INDUSTRY